• News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Digital edition
    • Archived issues
    • Media kit
    • Submit Press Release
  • White Papers
  • Events
  • Suppliers
  • E-Alert
  • Contact us
  • FREE newsletter subscription
  • Search
  • Menu Menu
International Hospital
  • AI
  • Cardiology
  • Oncology
  • Neurology
  • Genetics
  • Orthopaedics
  • Research
  • Surgery
  • Innovation
  • Medical Imaging
  • MedTech
  • Obs-Gyn
  • Paediatrics

Archive for category: E-News

E-News

Arab Health Congress to shed light on regional hypertension concerns

, 26 August 2020/in E-News /by 3wmedia

1st Gulf Hypertension Conference launches at Arab Health Congress 2015

Dubai, UAE: The Arab Health Congress has introduced a new conference to its already packed conference offering for 2015. The 1st Gulf Hypertension Conference is officially endorsed by the European Hypertension Society and it aims to provide the most updated clinical and scientific data to tackle the growing concerns with hypertension rates in the GCC and Middle East. Arab Health will bring together more than 30 world renowned experts to discuss current and future challenges and solutions in hypertension.

Arab Health Exhibition & Congress is organised by Informa Life sciences Exhibitions and will be held at the Dubai International Convention and Exhibitions Center from 26-29 January 2015. The largest multi-track medical congress returns for the 40th time to offer quality medical education to medical professionals working in the Middle East.

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:39:472020-08-26 14:40:09Arab Health Congress to shed light on regional hypertension concerns

Novel imaging technique improves prostate cancer detection

, 26 August 2020/in E-News /by 3wmedia

In 2014, prostate cancer was the leading cause of newly diagnosed cancers in men and the second leading cause of cancer death in men.  A team of scientists and physicians from the University of California, San Diego School of Medicine, with counterparts at University of California, Los Angeles, describe a novel imaging technique that measurably improves upon current prostate imaging

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:39:472020-08-26 14:39:59Novel imaging technique improves prostate cancer detection

MRI based on a sugar molecule can tell cancerous from noncancerous cells

, 26 August 2020/in E-News /by 3wmedia

Imaging tests like mammograms or CT scans can detect tumours, but figuring out whether a growth is or isn

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:39:472020-08-26 14:39:49MRI based on a sugar molecule can tell cancerous from noncancerous cells

Imaging study finds first evidence of neuroinflammation in brains of chronic pain patients

, 26 August 2020/in E-News /by 3wmedia

A new study from Massachusetts General Hospital (MGH) investigators has found, for the first time, evidence of neuroinflammation in key regions of the brains of patients with chronic pain.  By showing that levels of an inflammation-linked protein are elevated in regions known to be involved in the transmission of pain, the study paves the way for the exploration of potential new treatment strategies and identifies a possible way around one of the most frustrating limitations in the study and treatment of chronic pain

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:39:472020-08-26 14:39:57Imaging study finds first evidence of neuroinflammation in brains of chronic pain patients

International award for low cost inflatable baby incubator

, 26 August 2020/in E-News /by 3wmedia

A Loughborough University graduate has won the International James Dyson Award with his life saving low cost inflatable baby incubator for use in the developing world.

Over one in ten babies worldwide are born prematurely. According to the World Health Organisation, 75% of deaths resulting from premature birth could be avoided if inexpensive treatments were more readily available across the globe.

Created by James Roberts, MOM provides the same performance as a

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:39:472020-08-26 14:40:04International award for low cost inflatable baby incubator

New nanodevice defeats drug resistance

, 26 August 2020/in E-News /by 3wmedia

Chemotherapy often shrinks tumours at first, but as cancer cells become resistant to drug treatment, tumours can grow back. A new nanodevice developed by MIT researchers can help overcome that by first blocking the gene that confers drug resistance, then launching a new chemotherapy attack against the disarmed tumours.

The device, which consists of gold nanoparticles embedded in a hydrogel that can be injected or implanted at a tumour site, could also be used more broadly to disrupt any gene involved in cancer.

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:39:472020-08-26 14:39:52New nanodevice defeats drug resistance

Nearly one in five women who undergo hysterectomy may not need the procedure

, 26 August 2020/in E-News /by 3wmedia

It is estimated that one in three women in the United States will have had a hysterectomy by the age of 60. Although the numbers of hysterectomies are decreasing, a new study of more than three thousand women in Michigan who underwent hysterectomy for benign indications reveals that alternatives to hysterectomy are being underused and that treatment guidelines are often not followed. Post-surgical pathology showed that nearly one in five (18%) of hysterectomies that were done for benign indications were unnecessary, and that nearly two in five (37.8%) of women under 40 had unsupportive pathology.

Over 400,000 hysterectomies are performed in the US each year. About 68% of surgeries for benign conditions are done because of abnormal uterine bleeding, uterine fibroids, and endometriosis. The American Congress of Obstetricians and Gynecologists recommends alternatives to hysterectomy, including hormonal and other forms of medical management, operative hysteroscopy, endometrial ablation, and use of the levonorgestrel intrauterine device as primary management of these conditions in many cases.

‘Over the past decade, there has been a substantial decline in the number of hysterectomies performed annually in the United States,’ observes senior investigator Daniel M. Morgan, MD, Associate Professor of Obstetrics and Gynecology at the University of Michigan. ‘An earlier study found a 36.4% decrease in number of hysterectomies performed in the U.S. in 2010 compared to 2002. However, despite the decrease in numbers of hysterectomies in the U.S., appropriateness of hysterectomy is still an area of concern and it continues to be a target for quality improvement.’

Investigators set out to assess how often alternatives to hysterectomy are being recommended to women with benign gynaecologic disease before performing hysterectomy and how often the pathologic findings from the hysterectomy supported an indication for surgery. They examined the medical records of 3,397 women who underwent hysterectomies for benign conditions in Michigan with these goals in mind. Data were collected over a ten-month period in 2013 from 52 hospitals participating in the Michigan Surgery Quality Collaborative (MSQC). Indications for surgery included uterine fibroids, abnormal uterine bleeding, endometriosis, or pelvic pain.

Nearly 40% of women did not have documentation of alternative treatment before their hysterectomy. Fewer than 30% received medical therapy, while 24% underwent other minor surgical procedures before the hysterectomy. Alternative treatment was more likely to be considered among women under 40 years old and among women with larger uteri. About 68% of women under 40 received alternative treatment compared with 62% of those aged 40-50 and 56% of those aged 50 or above.

Nearly one in five women (18.3%) had postsurgical pathologic findings that did not support having undergone a hysterectomy. The rate of unsupportive pathology was highest among women under 40 years. Nearly two in five women under 40 (37.8%) had pathologic findings that did not support undergoing a hysterectomy versus those aged 40-50 (12%) and over 50 years (7.5%). The frequency of unsupportive pathology was highest among women with a pre-operative diagnosis of endometriosis or chronic pain.

‘This study provides evidence that alternatives to hysterectomy are underutilized in women undergoing hysterectomy for abnormal uterine bleeding, uterine fibroids, endometriosis, or pelvic pain,’ says Dr. Morgan.

‘Although quality in gynaecologic surgery has focused on care after a procedure, these findings suggest that appropriateness of surgery could serve as an important quality metric in gynaecology,’ comments noted expert Jason D. Wright, MD, Chief of the Division of Gynecologic Oncology and Sol Goldman Associate Professor of Obstetrics and Gynecology at Columbia University College of Physicians and Surgeons and New York Presbyterian Hospital, New York.

Dr. Wright adds: ‘Reducing the number of procedures performed in women who may not necessarily require the procedure in the first place has the potential to have an even more meaningful impact in reducing adverse outcomes and cost than optimization of postoperative care. As reimbursement policies shift, appropriateness of surgery will likely become an even greater imperative from patients and payers.’ EurekAlert

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:39:472020-08-26 14:39:59Nearly one in five women who undergo hysterectomy may not need the procedure

Vibratory stimulation applied to the sole of the foot shows promise for fall

, 26 August 2020/in E-News /by 3wmedia

Findings show that imperceptible vibratory stimulation applied to the soles of the feet improved balance by reducing postural sway and gait variability in elderly study participants. The vibratory stimulation is delivered by a urethane foam insole with embedded piezoelectric actuators, which generates the mechanical stimulation. The study was conducted by researchers from the Institute for Aging Research (IFAR) at Hebrew SeniorLife, Beth Israel Deaconess Medical Center, the Wyss Institute for Biologically Inspired Engineering at Harvard University, and Harvard Medical School, all of Boston, Massachusetts; and Merck Sharpe and Dohme (MSD) Consumer Care, Inc., of Memphis, Tennessee.

These findings are significant because poor balance and an irregular gait are directly related to fall risk. Falls are the leading cause of death from injury among seniors. Risk increases with age and even the fear of falling can reduce quality of life.

1 in 3 seniors falls each year, and 25% of those who fall suffer moderate to severe injuries, such as hip fractures.
Only 25% of hip fracture patients make a full recovery; 40% require nursing home care; and nearly 25% die within 12 months.
By 2020, the annual direct and indirect cost of fall injuries is expected to reach nearly $55 billion.
‘Although loss of sensation in the feet is a common problem among elderly people that can impair balance and gait and result in falls, there are currently no interventions available that can reverse sensory impairments and prevent these dangerous consequences,’ said study lead author Lewis Lipsitz, M.D., Director of the Institute for Aging Research. ‘We were very excited to discover that small amounts of vibratory noise applied to the soles of the feet may be able to do just that.’

This study follows earlier research that looked at how the physical principle of stochastic resonance could be applied to mitigate deficits in the human somatosensory systems that develop due to disease, injury, or age. The somatosensory system informs us about objects in our external environment through touch. Receptors are distributed all over the body and different types of receptors respond to many different kinds of stimuli. Stochastic resonance (SR) is a phenomenon whereby the detectability of weak signals in certain types of systems can be improved through the careful addition of low

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:39:472020-08-26 14:40:07Vibratory stimulation applied to the sole of the foot shows promise for fall

Advanced 3-D facial imaging may aid in early detection of autism

, 26 August 2020/in E-News /by 3wmedia

Autism is a spectrum of closely related disorders diagnosed in patients who exhibit a shared core of symptoms, including delays in learning to communicate and interact socially. Early detection of autism in children is the key for treatments to be most effective and produce the best outcomes. Using advanced three-dimensional imaging and statistical analysis techniques, researchers at the University of Missouri have identified facial measurements in children with autism that may lead to a screening tool for young children and provide clues to its genetic causes.

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:39:472020-08-26 14:39:54Advanced 3-D facial imaging may aid in early detection of autism

A new tool for identifying onset of local influenza outbreaks

, 26 August 2020/in E-News /by 3wmedia

Predicting the beginning of influenza outbreaks is notoriously difficult, and can affect prevention and control efforts. Now, just in time for flu season, biostatistician Nicholas Reich of the University of Massachusetts Amherst and colleagues at Johns Hopkins have devised a simple yet accurate method for hospitals and public health departments to determine the onset of elevated influenza activity at the community level.

Hospital epidemiologists and others responsible for public health decisions do not declare the start of flu season lightly, Reich explains. In hospitals, a declaration that flu season has started comes with many extra precautions and procedures such as added gloves, masks and gowns, donning and doffing time, special decontamination procedures, increased surveillance and reduced visitor access, for example.

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:39:472020-08-26 14:40:02A new tool for identifying onset of local influenza outbreaks
Page 131 of 239«‹129130131132133›»

Latest issue of International Hospital

April 2024

28 November 2025

UK government commits £74 million to life sciences innovation

28 November 2025

CAR T cells reduce atherosclerosis by 70% in mouse study

28 November 2025

GE HealthCare launches Carevance patient monitor with cardiac output insights

Digital edition
All articles Archived issues

Free subscription

View more product news

Get our e-alert

The medical devices information portal connecting healthcare professionals to global vendors

Sign in for our newsletter
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Archived issues
    • Media kit
    • Submit Press Release

Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@interhospi.com

PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.

Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Accept settingsHide notification onlyCookie settings

Cookie and Privacy Settings



How we use cookies

We may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.

Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.

We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.

We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.

.

Google Analytics Cookies

These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.

If you do not want us to track your visit to our site, you can disable this in your browser here:

.

Other external services

We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page

Google Webfont Settings:

Google Maps Settings:

Google reCaptcha settings:

Vimeo and Youtube videos embedding:

.

Privacy Beleid

U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.

Privacy policy
Accept settingsHide notification only

Sign in for our newsletter

Free subscription